KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,171.00
+16.00 (1.39%)
Aug 25, 2026, 3:30 PM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 66.35 billion as of August 24, 2026. Its market cap has decreased by -26.20% in one year.
Market Cap
66.35B
Enterprise Value
72.64B
Revenue
125.68B
Ranking
n/a
PE Ratio
30.55
Stock Price
1,171.00
ChartMarket Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 66.35B, an increase of 263.68%. That is a compound annual growth rate of 6.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 66.35B | -24.86% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Towa Pharmaceutical | 191.74B |
| Sawai Group Holdings | 188.47B |
| Kissei Pharmaceutical | 169.75B |
| Kaken Pharmaceutical | 150.90B |
| Mochida Pharmaceutical | 115.25B |
| Zeria Pharmaceutical | 94.90B |
| ASKA Pharmaceutical Holdings | 61.62B |
| Fuji Pharma | 48.24B |